Autres langues Virbac

Actions

Marché Fermé - Euronext Paris 17:55:00 30/09/2026			Varia. 5j.	Varia. 1 janv.
311,50 ^EUR	+0,32%		+1,30%	-12,87%

22/09	Virbac "regarde activement les opportunités d'acquisition"
21/09	Les derniers choix des stars de la gestion : un bel été, mais une rentrée compliquée

28/09	Virbac : Evolution of the Virbac Board of Directors
18/09	French and Benelux stocks-Factors to watch on September 18
17/09	Virbac : Public release of the Half-Year Financial Report at 30 June 2026
17/09	Virbac : Half-Year report 2026
17/09	Virbac SA Reports Earnings Results for the Half Year Ended June 30, 2026
17/09	Virbac SA Updates Earnings Guidance for the Year 2026
17/09	Virbac confirms outlook as Supercharge platforms drive profit growth
17/09	Virbac : 2026 half-year results
17/09	Virbac reports 6.8% rise in first-half core profit
17/09	VIRBAC: A robust adjusted EBIT margin² of 18.8%, driven by solid organic revenue growth of 7.4%
20/08	Cancer vaccines finally garner the spotlight
30/07	Virbac - ohne Ausreden zum Erfolg
30/07	Virbac, sin excusas
29/07	Virbac, het ontbrekende excuus
29/07	Virbac, without the alibi
21/07	Virbac : Impressive execution in Q2; we smell a guidance upgrade in Q3
20/07	Virbac : 2026 second quarter consolidated sales
20/07	Virbac: solid growth of +7.4% at CERS in H1 2026, fueled by double-digit growth of our Supercharge4 platforms
14/07	Where would AI lead Pharma in the long run?
27/05	Governance: regional reorganization to foster proximity
05/05	Virbac : Step into the Daily Life of an Iberian Pig Farm Manager
27/04	Virbac : Public release of Virbac Annual Report at 31 December 2025.
17/04	Virbac : 2026 starts on strong footing
17/04	Swine health: Virbac signs agreement with MACSO
17/04	French and Benelux stocks-Factors to watch April 17